Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncotarget|December 22, 2017
Advances in the understanding and management of T-cell prolymphocytic leukemiaKamel Laribi, Pierre Lemaire, Jeremy Sandrini, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 18, 2018
Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent PatentsKamel Laribi, Mustapha Alani, Catherine Truong, et al.
Annals of Hematology|April 2, 2021
Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: reviewKamel Laribi, Mohamad Sobh, David Ghez, et al.
The Oncologist|April 21, 2018
Recent Advances in the Treatment of Peripheral T-Cell LymphomaKamel Laribi, Mustapha Alani, Catherine Truong, et al.
Clinical Case Reports|March 14, 2015
Meningeal involvement in multiple myelomaKamel Laribi, Charles Mellerio, Alix Baugier, et al.
Clinical Case Reports|January 20, 2016
Quadri-lineage disease involving nodal B-cell marginal zone lymphoma, high-grade B-cell lymphoma, Kaposi's syndrome, and acute myeloid leukemiaKamel Laribi, Habib Ghnaya, Pierre-Jean Mention, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 31, 2016
Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted TherapiesKamel Laribi, Nathalie Denizon, Anne Besançon, et al.
Cancer Medicine|April 18, 2019
Impact of the relative dose intensity on survival of patients with high-risk myelodysplastic syndromes treated with AzacitidineKamel Laribi, Delphine Bolle, Mustafa Alani, et al.
Annals of Hematology|February 10, 2016
Rituximab is an effective and safe treatment of relapse in elderly patients with resistant warm AIHAKamel Laribi, Delphine Bolle, Habib Ghnaya, et al.
Experimental Hematology|June 9, 2018
Prognostic impact of elevated pretreatment serum ferritin in patients with high-risk MDS treated with azacitidineKamel Laribi, Delphine Bolle, Mustapha Alani, et al.
Pageof 2